Ironwood Pharma (IRWD) Financial Statements

435 Followers

Ironwood Pharma Financial Overview

Ironwood Pharma's market cap is currently $676.69M. The company's EPS TTM is $; its P/E ratio is 22.76; Ironwood Pharma is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 296.15M	$ 351.41M	$ 442.74M	$ 410.60M	$ 413.75M
Gross Profit	$ 294.27M	$ 343.86M	$ 436.59M	$ 409.18M	$ 343.35M
Operating Income	$ 118.76M	$ 93.12M	$ -945.43M	$ 250.34M	$ 232.26M
EBITDA	$ 104.65M	$ 97.73M	$ 197.41M	$ 261.44M	$ 233.74M
Net Income	$ 24.02M	$ 880.00K	$ -1.00B	$ 175.06M	$ 528.45M
Balance Sheet
Cash & Short-Term Investments	$ 215.46M	$ 88.56M	$ 92.15M	$ 656.20M	$ 620.13M
Total Assets	$ 396.90M	$ 350.91M	$ 471.07M	$ 1.10B	$ 1.13B
Total Debt	$ 597.80M	$ 599.48M	$ 715.54M	$ 415.92M	$ 475.80M
Net Debt	$ 382.35M	$ 510.92M	$ 623.38M	$ -240.29M	$ -144.33M
Total Liabilities	$ 658.74M	$ 652.24M	$ 817.37M	$ 448.14M	$ 521.02M
Stockholders' Equity	$ -261.83M	$ -301.33M	$ -346.30M	$ 652.38M	$ 605.91M
Cash Flow
Free Cash Flow	$ 127.01M	$ 103.41M	$ 183.15M	$ 273.63M	$ 261.63M
Operating Cash Flow	$ 127.04M	$ 103.55M	$ 183.43M	$ 273.76M	$ 261.89M
Investing Cash Flow	$ -34.00K	$ -142.00K	$ -1.03B	$ -136.00K	$ -265.00K
Financing Cash Flow	$ 216.00K	$ -106.97M	$ 277.16M	$ -237.55M	$ -4.55M

Currency in USD

Ironwood Pharma Earnings and Revenue History

Income Statement >

Ironwood Pharma Debt to Assets

Balance Sheet >

Ironwood Pharma Cash Flow

Cash Flow >

Ironwood Pharma Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >